|

DOAC Clinical Trials

2 actively recruiting trials

Pipeline

Phase 4: 1

Top Sponsors

  • Insel Gruppe AG, University Hospital Bern2

Indications

  • Heart Disease2
  • P2Y12 Inhibitor1
  • Oral Anticoagulation1
  • Percutaneous Coronary Intervention (PCI)1
  • Atrial Fibrillation (AF)1

Other2 trials

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
N/A
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.